EGFP saRNA (Cap-1, 5mCTP)

Item number	Size	Manual	Delivery time	Price
Cay45065-100	100 µg	-	5 - 10 business days*	674.00€
Cay45065-500	500 µg	-	5 - 10 business days*	2,693.00€
Cay45065-1	1 mg	-	5 - 10 business days*	5,050.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

EGFP self-amplifying RNA (saRNA) (Cap-1, 5mCTP) encodes enhanced GFP (EGFP), a variant of A.... more

Close menu

Product information "EGFP saRNA (Cap-1, 5mCTP)"

EGFP self-amplifying RNA (saRNA) (Cap-1, 5mCTP) encodes enhanced GFP (EGFP), a variant of A. victoria GFP containing chromophore mutations that increase the sensitivity of the protein and displays excitation/emission maxima of 489/511 nm, respectively. It is capped with the Cap-1 structure to increase translation efficiency and modified with 5-methylcytidine-5'-triphosphate (5mCTP) to reduce the host cell immune response. EGFP saRNA (Cap-1, 5mCTP) is based on the self-replicating Venezuelan equine encephalitis virus (VEEV), which results in stable expression of EGFP. It can be used as a control for the delivery and translation efficiency of RNA. Encapsulation of EGFP saRNA in lipid nanoparticles (LNPs) has been used for saRNA delivery and expression of EGFP in vitro.. SMILES: . InChi Code: . InChi Key:

Keywords:	Enhanced GFP Self-amplifying RNA
Supplier:	Cayman Chemical
Supplier-Nr:	45065

Properties

Application:	EGFP expression
Format:	Liquid

Database Information

Handling & Safety

Storage:	-80°C
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "EGFP saRNA (Cap-1, 5mCTP)"

Write a review